logo

Synthesis and biodistribution of [131I]IMPY

RADIOCHEMISTRY, RADIOPHARMACEUTICALS AND NUCLEAR MEDICINE

Synthesis and biodistribution of [131I]IMPY

LU Chun-Xiong
WU Chun-Ying
JIANG Quan-Fu
Nuclear Science and TechniquesVol.16, No.5pp.289-292Published in print 01 Oct 2005
21600

The synthesis and biodistribution of β-amyloid plaques imaging agent [131I]-2- (4′-dimethylaminophenyl)-6-iodoimidazo[1,2-α] pyridine ([131I]IMPY) were reported. The chemical structure of the labeling precursor 2-(4′-dimethylaminophenyl)-6- (tributylstannyl) imidazo[1, 2-α] pyridine and all its intermediates were verified by IR,HNMR and MS. The radioiodinated compound was prepared using iododestannylation reaction by hydrogen peroxide. Final radiochemical purity was above 95% determined by TLC. The in vivo biodistribution of [131I]IMPY in normal mice showed excellent brain uptake and washout, indicating this thioflavin-T based small molecular probe has potential for in vivo imaging amyloid deposits.

β-amyloid plaques[131I]IMPYSynthesis
References
[1] Selkoe D J. Physiol Rev, 2001,81: 741-766
[2] Hardy J, Selkoe D J. Science, 2002, 297: 353-356
[3] Selkoe D J. Am Med Assoc, 2000,283: 1615-1617
[4] Kung M P, Hou C, Zhuang Z P, et al. Brain Research, 2002, 956: 202-210
[5] Kung M P, Skovronsky D, Hou C, et al. J Mol Nuerosci, 2003, 20: 15-24
[6] Zhuang Z P, Kung M P, Wilson A, et al. J Med Chem, 2003, 46: 237-243
[7] Kung M P, Hou C, Zhuang Z P, et al. Euro J Nucl Med Molec Imag, 2004, In Press
[8] Sundberg R J, Dahlhausen D J, Manikumar G, et al. J Heterocyclic Chem, 1988, 25: 129